Cargando…

The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species

Systemic sclerosis (SSc) is a multi-system connective tissue disease characterized by the increased deposition of extracellular matrix proteins such as collagen and fibronectin. Although the pathogenesis is not completely understood, a number of studies suggest that free radicals could be the major...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Luigi, Luigi, Duranti, Guglielmo, Antonioni, Ambra, Sgrò, Paolo, Ceci, Roberta, Crescioli, Clara, Sabatini, Stefania, Lenzi, Andrea, Caporossi, Daniela, Del Galdo, Francesco, Dimauro, Ivan, Antinozzi, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555932/
https://www.ncbi.nlm.nih.gov/pubmed/32854347
http://dx.doi.org/10.3390/antiox9090786
_version_ 1783594122252124160
author Di Luigi, Luigi
Duranti, Guglielmo
Antonioni, Ambra
Sgrò, Paolo
Ceci, Roberta
Crescioli, Clara
Sabatini, Stefania
Lenzi, Andrea
Caporossi, Daniela
Del Galdo, Francesco
Dimauro, Ivan
Antinozzi, Cristina
author_facet Di Luigi, Luigi
Duranti, Guglielmo
Antonioni, Ambra
Sgrò, Paolo
Ceci, Roberta
Crescioli, Clara
Sabatini, Stefania
Lenzi, Andrea
Caporossi, Daniela
Del Galdo, Francesco
Dimauro, Ivan
Antinozzi, Cristina
author_sort Di Luigi, Luigi
collection PubMed
description Systemic sclerosis (SSc) is a multi-system connective tissue disease characterized by the increased deposition of extracellular matrix proteins such as collagen and fibronectin. Although the pathogenesis is not completely understood, a number of studies suggest that free radicals could be the major contributors to the disease. Indeed, different studies demonstrated how oxidative stress could contribute to the fibrotic process activation at the level of the skin and visceral organs. Emerging evidences highlight the beneficial effects of sildenafil, a phosphodiesterase type 5 inhibitor (PDE5i), which protects different cell lines from the cell damage induced by reactive oxygen species (ROS). These data make sildenafil a good candidate for therapeutic treatment aimed to protect biological macromolecules against oxidative damage, thus preserving cell viability. The purpose of this study was to evaluate the sensitivity of SSc dermal fibroblasts to an oxidative insult and the ability for sildenafil to prevent/reduce the DNA damage due to ROS action. Additionally, we evaluated the capacity for sildenafil to influence redox homeostasis and cytotoxicity, as well as cell proliferation and cell cycle progression. We demonstrated that SSc fibroblasts have an increased sensitivity to a pro-oxidant environment in comparison to healthy controls. The sildenafil treatment reduced ROS-induced DNA damage, counteracted the negative effects of ROS on cell viability and proliferation, and promoted the activity of specific enzymes involved in redox homeostasis maintenance. To our knowledge, in this report, we demonstrate, for the first time, that sildenafil administration prevents ROS-induced instability in human dermal fibroblasts isolated by SSc patients. These results expand the use of PDE5i as therapeutic agents in SSc by indicating a protective role in tissue damage induced by oxidative insult.
format Online
Article
Text
id pubmed-7555932
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75559322020-10-19 The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species Di Luigi, Luigi Duranti, Guglielmo Antonioni, Ambra Sgrò, Paolo Ceci, Roberta Crescioli, Clara Sabatini, Stefania Lenzi, Andrea Caporossi, Daniela Del Galdo, Francesco Dimauro, Ivan Antinozzi, Cristina Antioxidants (Basel) Article Systemic sclerosis (SSc) is a multi-system connective tissue disease characterized by the increased deposition of extracellular matrix proteins such as collagen and fibronectin. Although the pathogenesis is not completely understood, a number of studies suggest that free radicals could be the major contributors to the disease. Indeed, different studies demonstrated how oxidative stress could contribute to the fibrotic process activation at the level of the skin and visceral organs. Emerging evidences highlight the beneficial effects of sildenafil, a phosphodiesterase type 5 inhibitor (PDE5i), which protects different cell lines from the cell damage induced by reactive oxygen species (ROS). These data make sildenafil a good candidate for therapeutic treatment aimed to protect biological macromolecules against oxidative damage, thus preserving cell viability. The purpose of this study was to evaluate the sensitivity of SSc dermal fibroblasts to an oxidative insult and the ability for sildenafil to prevent/reduce the DNA damage due to ROS action. Additionally, we evaluated the capacity for sildenafil to influence redox homeostasis and cytotoxicity, as well as cell proliferation and cell cycle progression. We demonstrated that SSc fibroblasts have an increased sensitivity to a pro-oxidant environment in comparison to healthy controls. The sildenafil treatment reduced ROS-induced DNA damage, counteracted the negative effects of ROS on cell viability and proliferation, and promoted the activity of specific enzymes involved in redox homeostasis maintenance. To our knowledge, in this report, we demonstrate, for the first time, that sildenafil administration prevents ROS-induced instability in human dermal fibroblasts isolated by SSc patients. These results expand the use of PDE5i as therapeutic agents in SSc by indicating a protective role in tissue damage induced by oxidative insult. MDPI 2020-08-25 /pmc/articles/PMC7555932/ /pubmed/32854347 http://dx.doi.org/10.3390/antiox9090786 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Di Luigi, Luigi
Duranti, Guglielmo
Antonioni, Ambra
Sgrò, Paolo
Ceci, Roberta
Crescioli, Clara
Sabatini, Stefania
Lenzi, Andrea
Caporossi, Daniela
Del Galdo, Francesco
Dimauro, Ivan
Antinozzi, Cristina
The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species
title The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species
title_full The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species
title_fullStr The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species
title_full_unstemmed The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species
title_short The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species
title_sort phosphodiesterase type 5 inhibitor sildenafil improves dna stability and redox homeostasis in systemic sclerosis fibroblasts exposed to reactive oxygen species
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555932/
https://www.ncbi.nlm.nih.gov/pubmed/32854347
http://dx.doi.org/10.3390/antiox9090786
work_keys_str_mv AT diluigiluigi thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT durantiguglielmo thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT antonioniambra thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT sgropaolo thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT ceciroberta thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT crescioliclara thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT sabatinistefania thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT lenziandrea thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT caporossidaniela thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT delgaldofrancesco thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT dimauroivan thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT antinozzicristina thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT diluigiluigi phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT durantiguglielmo phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT antonioniambra phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT sgropaolo phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT ceciroberta phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT crescioliclara phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT sabatinistefania phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT lenziandrea phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT caporossidaniela phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT delgaldofrancesco phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT dimauroivan phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies
AT antinozzicristina phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies